Saudi Arabia SFDA Medical Device Registration

Regulatory Oversight of SFDA

The commercial distribution of medical devices and in vitro diagnostics in Saudi Arabia is governed by the Saudi Food and Drug Authority, commonly referred to as SFDA. This agency is responsible for enforcing the Medical Devices Law and the Implementing Regulation of Medical Devices Law to ensure the safety and effectiveness of products. Their oversight extends to both imported and locally manufactured products, encompassing classification, registration, and market surveillance.

Risk Classification for Medical Devices and IVD

The SFDA utilizes a risk-based classification system for both general medical devices and In Vitro Diagnostics (IVD) based on their potential impact on individuals and public health.

• Class D represents high-risk products such as life-supporting equipment or highly infectious disease diagnostic kits.
• Class C includes moderate-to-high risk items such as orthopedic implants and specialized diagnostic tests.
• Class B covers moderate-risk technologies such as surgical gloves and certain self-testing kits.
• Class A consists of low-risk products such as simple bandages and basic laboratory reagents.

Core Prerequisites for Market Access

To successfully enter the Saudi market, manufacturers must satisfy specific technical and quality requirements mandated by the SFDA. This involves providing detailed product descriptions, risk management files, and evidence of clinical evaluation to demonstrate compliance with safety regulations. While the SFDA does not strictly mandate CE marking, products already possessing a CE mark may face a more streamlined verification process. Furthermore, all technical documentation and labeling materials must be provided in English to facilitate the regulatory review.

Registration Pathway and Representative Duties

The administrative process for market access relies on a structured sequence of evaluations involving a local presence within the Kingdom.

Appointment of an Authorized Representative

Foreign manufacturers are required to designate a Saudi Arabia Authorized Representative (AR). This entity must be a legal person or organization established within Saudi Arabia and holds a specific license issued by the SFDA to act on the manufacturer's behalf. The AR is responsible for compiling the Medical Device Marketing Authorization (MDMA) technical file and serving as the primary liaison with the SFDA.

Assessment and Final Authorization

The registration process follows a specific flow beginning with the appointment of the AR and the preparation of the MDMA technical file. This is followed by the MDMA application submission and a technical review by the SFDA. The review period for an MDMA application typically ranges from two to three months, though complex devices may require more time. Upon successful evaluation, the SFDA issues the MDMA certificate, allowing the product to be legally marketed.

Administrative Timelines and Market Maintenance

The SFDA registration system is designed to monitor products throughout their lifecycle in the Saudi market.

• Processing times for MDMA applications are generally finalized within a few months once all documentation is submitted.
• Manufacturers must engage in post-market surveillance to identify and report any safety incidents or malfunctions to the SFDA.
• Ongoing compliance is required to maintain the validity of the MDMA certificate and ensure continued market access.

Proregulations' Saudi Arabia SFDA Registration Services

Our team facilitates a seamless transition into the Saudi Arabian market by managing the complexities of the Medical Devices Law through the following specialized service modules.

• Professional authorized representative appointment

We act as your officially designated Saudi Arabia AR to fulfill the legal requirement for a local entity to manage your MDMA applications and communications with the SFDA.

• Regulatory strategy and classification analysis

Our experts conduct a detailed review of your product specifications to determine the correct risk class and identify the most efficient registration pathway in accordance with SFDA standards.

• MDMA technical file and dossier compilation

We assist in the preparation of the comprehensive technical summary required for the MDMA application including risk assessments and clinical evaluation reports.

• SFDA application and MDMA management

We manage the entire submission process within the SFDA electronic system to ensure that all manufacturing data and technical evidence are accurately reported for a smooth approval.

• Clinical evaluation and post-market support

Our team provides guidance on presenting clinical evidence and establishing local monitoring procedures to satisfy SFDA requirements for safety and effectiveness.

• Compliance maintenance and certificate renewal

We ensure your market access remains uninterrupted by managing the necessary updates for your registration and coordinating the renewal of your MDMA certificates.

• Labeling and documentation review

We review your product labeling and instructions for use to ensure they meet the specific English language and technical requirements mandated by the SFDA.

If you are interested in our Saudi Arabia SFDA registration services and wish to secure your market position, please feel free to contact us.